TransMedics Group (TMDX) Tops Q1 EPS by 38c, raises outlook

TransMedics Group (NASDAQ: TMDX) reported Q1 EPS of $0.35, $0.38 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $96.85 million versus the consensus estimate of $83.76 million.

Outlook:

TransMedics Group sees FY2024 revenue of $390-400 million, versus the consensus of $366.9 million.

For earnings history and earnings-related data on TransMedics Group (TMDX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Paramount Global (PARA) Tops Q2 EPS by 480c
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08